AZTA
Azenta, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$34.84
+2.20%Year over year
Reported trailing growth
- Revenue
- +4.9%
- EBITDA
- —
- EBIT
- —
- EPS
- -13.6%
- Free cash flow
- -78.4%
- Operating cash flow
- -54.6%
Forward estimates
Based on analyst estimates
- Revenue
- +3.9%
- EBITDA
- +192.1%
- EPS
- +119.4%
Three-year CAGR
- Revenue
- +2.2%
- EBITDA
- +3.8%
- EBIT
- +62.4%
- Net income
- +66.2%
- EPS
- +60.5%
- Free cash flow
- +210.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026